Literature DB >> 12131299

Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection.

Lars Egevad1, Torvald Granfors, Lars Karlberg, Anders Bergh, Par Stattin.   

Abstract

PURPOSE: We investigated the value of percent Gleason grade 4/5 as a predictor of long-term outcome in men with prostate cancer diagnosed at transurethral resection who received deferred treatment.
MATERIALS AND METHODS: A series of 305 men with prostate cancer diagnosed at transurethral resection from 1975 to 1990 who had subsequent expectancy was analyzed. Mean patient age at diagnosis was 74 years (range 52 to 95). Slides were reviewed, and the Gleason score, percent Gleason grade 4/5 and modified Gleason score (the sum of the dominant and worst grades) were assessed.
RESULTS: At followup 271 men (89%) had died, including 110 (36%) of prostate cancer. Gleason score, percent Gleason grade 4/5 and modified Gleason score were significant predictors of disease specific survival (p <0.001). Of all men 34% had tumors without any grade 4/5 pattern, of whom only 8% died of prostate cancer compared with 52% with any grade 4/5 pattern (p <0.001). Gleason score 6 tumors with focal grade 4 (less than 5%) had a worse prognosis than pure Gleason score 3 + 3 = 6 tumors (p = 0.008). There was nonsignificantly shorter survival for Gleason score 4 + 3 = 7 than for Gleason score 3 + 4 = 7 disease (p = 0.19). In Cox models including all possible pairs of Gleason score, percent Gleason grade 4/5 and modified Gleason score the percent Gleason grade 4/5 and modified Gleason score were stronger than Gleason score, although all 3 were independently significant prognosticators.
CONCLUSIONS: Percent Gleason grade 4/5, modified Gleason score and Gleason score are predictors of disease specific survival in patients with prostate cancer on deferred treatment. Our study indicates that any grade 4/5 pattern impairs the prognosis significantly.

Entities:  

Mesh:

Year:  2002        PMID: 12131299

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

2.  Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading.

Authors:  Lars Egevad; Ferran Algaba; Daniel M Berney; Liliane Boccon-Gibod; Eva Compérat; Andrew J Evans; Rainer Grobholz; Glen Kristiansen; Cord Langner; Gina Lockwood; Antonio Lopez-Beltran; Rodolfo Montironi; Pedro Oliveira; Matthias Schwenkglenks; Ben Vainer; Murali Varma; Vincent Verger; Philippe Camparo
Journal:  Virchows Arch       Date:  2011-06-23       Impact factor: 4.064

3.  Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.

Authors:  Leonardo Kayat Bittencourt; Jelle O Barentsz; Luiz Carlos Duarte de Miranda; Emerson Leandro Gasparetto
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

4.  Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment.

Authors:  K R Keshari; H Tsachres; R Iman; L Delos Santos; Z L Tabatabai; K Shinohara; D B Vigneron; J Kurhanewicz
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

Review 5.  Histopathology of Prostate Cancer.

Authors:  Peter A Humphrey
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

6.  Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens.

Authors:  Axel Glaessgen; Hans Hamberg; Carl-Gustaf Pihl; Birgitta Sundelin; Bo Nilsson; Lars Egevad
Journal:  Virchows Arch       Date:  2004-05-20       Impact factor: 4.064

Review 7.  The role of metabolic imaging in radiation therapy of prostate cancer.

Authors:  V Y Zhang; A Westphalen; L Delos Santos; Z L Tabatabai; K Shinohara; D B Vigneron; J Kurhanewicz
Journal:  NMR Biomed       Date:  2013-08-12       Impact factor: 4.044

8.  The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.

Authors:  Daniel M Berney; Luis Beltran; Holly Sandu; Geraldine Soosay; Henrik Møller; Peter Scardino; Jacqueline Murphy; Amar Ahmad; Jack Cuzick
Journal:  Histopathology       Date:  2019-08-13       Impact factor: 5.087

9.  Risk subtyping and prognostic assessment of prostate cancer based on consensus genes.

Authors:  Jialin Meng; Yu Guan; Bijun Wang; Lei Chen; Junyi Chen; Meng Zhang; Chaozhao Liang
Journal:  Commun Biol       Date:  2022-03-15

10.  The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective study.

Authors:  Jiandong Liu; Jinge Zhao; Mengni Zhang; Ni Chen; Guangxi Sun; Yaojing Yang; Xingming Zhang; Junru Chen; Pengfei Shen; Ming Shi; Hao Zeng
Journal:  Cancer Manag Res       Date:  2019-07-12       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.